Biotin in multiple sclerosis in real world: a cohort of 50 patients

被引：0
|
作者：
Fromont, A. [1 ]
Romain, G. [2 ]
Vialatte, A. L. [1 ]
Maugest, L. [1 ]
Audry, D. [1 ]
Moreau, T. [1 ]
机构：
[1] Univ Hosp Dijon, Neurol, Dijon, France
[2] Univ Hosp Dijon, Epidemiol, Dijon, France
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P747
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [41] Real-world experience of ocrelizumab in multiple sclerosis patients in Latin America
    Ignacio Rojas, Juan
    Patrucco, Liliana
    Fruns, Manuel
    Hornung, Giesela
    Flores, Jose
    Carnero Contentti, Edgar
    Adrian Lopez, Pablo
    Pablo Pettinicchi, Juan
    Caride, Alejandro
    Galleguillos, Lorna
    Barahona, Jorge
    Diaz, Violeta
    Hernandez, Marianella
    Alonso, Ricardo
    Cristiano, Edgardo
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2021, 79 (04) : 305 - 309
  • [42] Safety and Effectiveness of Fingolimod in Real-World Multiple Sclerosis Portuguese Patients
    Ribeiro de Barros, Ariana Helena
    Fiadeiro Sequeira, Joao Paulo
    Lopes de Sousa, Ary Severino
    Chegancas Capela, Carlos Miguel
    Gomes Pedrosa, Rui Manuel
    dos Santos Manita, Manuel Alexandre
    CLINICAL NEUROPHARMACOLOGY, 2018, 41 (04) : 129 - 135
  • [43] Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting
    Rodriguez-Leal, Francisco Alejandro
    Haase, Rocco
    Akguen, Katja
    Eisele, Judith
    Proschmann, Undine
    Schultheiss, Thorsten
    Kern, Raimar
    Ziemssen, Tjalf
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10 : 1 - 11
  • [44] Evidence of Disease Activity-3 in Chinese Multiple Sclerosis Patients: A Multicentre, Retrospective, Real-World Cohort Study
    Feng, Jinzhou
    Fan, Moli
    Song, Tian
    Yao, Yajun
    Guo, Ai
    Yang, Xiaoxia
    Xu, Qiao
    Yang, Xiaolin
    Tian, Decai
    Shi, Fu-Dong
    Qin, Xinyue
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1080 - 1081
  • [45] Neurofascin 155, 186 and 140 Antibodies in a Cohort of Multiple Sclerosis Patients: A Prospective Real World Multi-Centre Study
    Mathew, Thomas
    Garg, Surabhi Anandswaroop
    Majumdar, Pritam
    Bhardwaj, Shagun
    Kannoth, Sudheeran
    Mathai, Annamma
    Murgod, Uday
    Kamath, Vikram
    Kaul, Subhash
    Nambiar, Sindhu
    Huddar, Akshata
    Shivde, Sonia
    Nadig, Raghunandan
    Kumar, Sharath G. G.
    Deepalam, Sai Kanth
    Sarma, Gosala Raja Kukkuta
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 886 - 887
  • [46] Treatment effects of fampridine on ambulation and upper extremity function in patients with multiple sclerosis from a real-world evidence cohort
    Kaya, L.
    van Munster, C. E. P.
    Lam, K. -H.
    Kalkers, N. F.
    Killestein, J.
    Uitdehaag, B.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 720 - 721
  • [47] Recurrence of disease activity after fingolimod discontinuation - observations in a real-world cohort with 433 multiple sclerosis patients.
    Cerda, N.
    Nagy, S.
    Sinnecker, T.
    Wurfel, J.
    Kuhle, J.
    Yaldizli, O.
    Kappos, L.
    Derfuss, T.
    Decard, B. F.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 73 - 74
  • [48] No clinical improvement in patients with low biotinidase activity levels in a cohort of progressive multiple sclerosis patients treated with high dose biotin
    Dulau, C.
    Brochet, B.
    Mesli, S.
    Liegey, J. -S.
    Deloire, M.
    Moroso, A.
    Ouallet, J. -C.
    Ruet, A.
    Redonnet-Vernhet, I.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 694 - 694
  • [49] Teriflunomide for multiple sclerosis in real-world setting
    Elkjaer, M. L.
    Molnar, T.
    Illes, Z.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (05): : 447 - 453
  • [50] Cladribine as treatment of multiple sclerosis, real world experience
    Celius, E. G.
    Berg-Hansen, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 527 - 528
12345